According to a report to the recently concluded 20th Communist Party of China (CPC) National Congress, China will steadily expand institutional opening up with regard to rules, regulations, management, and standards, while stressing high-standard opening up.
These words are “exciting” for Leon Wang, executive vice president, international and China president of pharmaceutical company AstraZeneca.
“China’s pursuit of high-standard opening up will inject more impetus to the global economic recovery and reinforce our confidence in expanding footprints here,” Wang said.
Along with unremitting opening-up efforts, an improving business environment, stable supply chains, and a bright market growth outlook are all part of China’s great appeal to foreign investors who seek long-term investment opportunities.
